| Schedule of Reportable Segment Financial Information |
The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations. Reportable Segment Financial Information (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, 2026 | | EMG | | EIG | | Corporate | | Total Consolidated | | Net Sales | $ | 777,985 | | | $ | 1,442,321 | | | $ | — | | | $ | 2,220,306 | | Cost of sales (1) | 541,090 | | | 868,782 | | | — | | | 1,409,872 | | | Selling expense | 26,886 | | | 166,796 | | | — | | | 193,682 | | | Segment Operating Income | 210,009 | | | 406,743 | | | — | | | 616,752 | | | Corporate G&A | — | | | — | | | 31,803 | | | 31,803 | | | Operating Income | 210,009 | | | 406,743 | | | (31,803) | | | 584,949 | | | Interest expense | — | | | — | | | (39,822) | | | (39,822) | | Other (expense) income, net (2) | — | | | — | | | (23,212) | | | (23,212) | | | Income before Income Taxes | $ | 210,009 | | | $ | 406,743 | | | $ | (94,837) | | | $ | 521,915 | | | | | | | | | | | Depreciation | 14,826 | | | 19,229 | | | 1,479 | | | 35,534 | | | Amortization | 21,805 | | | 58,294 | | | — | | | 80,099 | | | Total depreciation and amortization | $ | 36,631 | | | $ | 77,523 | | | $ | 1,479 | | | $ | 115,633 | | | | | | | | | | Research, Development & Engineering costs (3) | $ | 22,979 | | | $ | 82,437 | | | $ | — | | | $ | 105,416 | | | | | | | | | | | Assets | $ | 6,696,443 | | | $ | 14,819,458 | | | $ | 872,634 | | | $ | 22,388,535 | | | | | | | | | | | Capital Expenditures | $ | 9,227 | | | $ | 16,931 | | | $ | 7,085 | | | $ | 33,243 | |
(1)Includes $9.8 million of acquisition-related integration costs. (2)Includes $18.1 million of acquisition-related transaction costs. (3)Included in cost of sales. | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, 2025 | | EMG | | EIG | | Corporate | | Total Consolidated | | Net Sales | $ | 646,309 | | | $ | 1,246,332 | | | $ | — | | | $ | 1,892,641 | | Cost of sales (1) | 460,061 | | | 746,444 | | | — | | | 1,206,505 | | | Selling expense | 22,373 | | | 147,451 | | | — | | | 169,824 | | | Segment Operating Income | 163,875 | | | 352,437 | | | — | | | 516,312 | | | Corporate G&A | — | | | — | | | 27,932 | | | 27,932 | | | Operating Income | 163,875 | | | 352,437 | | | (27,932) | | | 488,380 | | | Interest expense | — | | | — | | | (22,514) | | | (22,514) | | Other (expense) income, net (2) | — | | | — | | | (17,901) | | | (17,901) | | | Income before Income Taxes | $ | 163,875 | | | $ | 352,437 | | | $ | (68,347) | | | $ | 447,965 | | | | | | | | | | | Depreciation | $ | 14,964 | | | $ | 19,409 | | | $ | 1,407 | | | $ | 35,780 | | | Amortization | 18,711 | | | 48,587 | | | — | | | 67,298 | | | Total depreciation and amortization | $ | 33,675 | | | $ | 67,996 | | | $ | 1,407 | | | $ | 103,078 | | | | | | | | | | Research, Development & Engineering costs (3) | $ | 19,995 | | | $ | 74,686 | | | $ | — | | | $ | 94,681 | | | | | | | | | | | Assets | $ | 4,837,524 | | | $ | 10,717,580 | | | $ | 627,153 | | | $ | 16,182,257 | | | | | | | | | | | Capital Expenditures | $ | 7,929 | | | $ | 12,984 | | | $ | — | | | $ | 20,913 | |
(1)Includes $7.8 million of acquisition-related integration costs. (2)Includes $12.0 million of acquisition-related transaction costs. (3)Included in cost of sales. | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, 2026 | | EMG | | EIG | | Corporate | | Total Consolidated | | Net Sales | $ | 2,165,130 | | | $ | 4,028,010 | | | $ | — | | | $ | 6,193,140 | | Cost of sales (1) | 1,520,307 | | | 2,409,799 | | | — | | | 3,930,106 | | | Selling expense | 74,731 | | | 467,808 | | | — | | | 542,539 | | | Segment Operating Income | 570,092 | | | 1,150,403 | | | — | | | 1,720,495 | | | Corporate G&A | — | | | — | | | 92,417 | | | 92,417 | | | Operating Income | 570,092 | | | 1,150,403 | | | (92,417) | | | 1,628,078 | | Interest expense (2) | — | | | — | | | (90,832) | | | (90,832) | | Other (expense) income, net (3) | — | | | — | | | (29,979) | | | (29,979) | | | Income before Income Taxes | $ | 570,092 | | | $ | 1,150,403 | | | $ | (213,228) | | | $ | 1,507,267 | | | | | | | | | | | Depreciation | $ | 46,004 | | | $ | 57,824 | | | $ | 4,771 | | | $ | 108,599 | | | Amortization | 59,019 | | | 159,436 | | | — | | | 218,455 | | | Total depreciation and amortization | $ | 105,023 | | | $ | 217,260 | | | $ | 4,771 | | | $ | 327,054 | | | | | | | | | | Research, Development & Engineering costs (4) | $ | 67,609 | | | $ | 260,304 | | | $ | — | | | $ | 327,913 | | | | | | | | | | | | | | | | | | | Capital Expenditures | $ | 29,479 | | | $ | 45,447 | | | $ | 15,796 | | | $ | 90,722 | |
(1)Includes $27.6 million of acquisition-related integration costs. (2)Includes $10.0 million of acquisition-related financing fees. (3)Includes $18.1 million of acquisition-related transaction costs. (4)Included in cost of sales.
| | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, 2025 | | EMG | | EIG | | Corporate | | Total Consolidated | | Net Sales | $ | 1,853,092 | | | $ | 3,549,576 | | | $ | — | | | $ | 5,402,668 | | Cost of sales (1) | 1,349,981 | | | 2,105,662 | | | — | | | 3,455,643 | | | Selling expense | 66,630 | | | 392,999 | | | — | | | 459,629 | | | Segment Operating Income | 436,481 | | | 1,050,915 | | | — | | | 1,487,396 | | | Corporate G&A | — | | | — | | | 82,561 | | | 82,561 | | | Operating Income | 436,481 | | | 1,050,915 | | | (82,561) | | | 1,404,835 | | | Interest expense | — | | | — | | | (58,364) | | | (58,364) | | Other (expense) income, net (2) | — | | | — | | | (22,115) | | | (22,115) | | | Income before Income Taxes | $ | 436,481 | | | $ | 1,050,915 | | | $ | (163,040) | | | $ | 1,324,356 | | | | | | | | | | | Depreciation | $ | 46,022 | | | $ | 57,296 | | | $ | 4,324 | | | $ | 107,642 | | | Amortization | 72,166 | | | 137,338 | | | — | | | 209,504 | | | Total depreciation and amortization | $ | 118,188 | | | $ | 194,634 | | | $ | 4,324 | | | $ | 317,146 | | | | | | | | | | Research, Development & Engineering costs (3) | $ | 62,270 | | | $ | 221,503 | | | $ | — | | | $ | 283,773 | | | | | | | | | | | | | | | | | | | Capital Expenditures | $ | 25,286 | | | $ | 34,653 | | | $ | 13,312 | | | $ | 73,251 | |
(1)Includes $7.8 million of acquisition-related integration costs. (2)Includes $12.0 million of acquisition-related transaction costs. (3)Included in cost of sales.
|